Kenya is stuck between a new global virus rulebook and a rich friend's deal. The country joins the World Health Organization talks to create a system for sharing pathogen data and benefits fairly. This happens while moving forward with a separate health agreement with the United States. The US deal provides billions in funding but requires Kenya to share pathogen data within one day of discovery.
Health experts warn the bilateral pact could undermine the WHO framework. They fear Kenya might give away valuable genetic sequence data without guaranteed benefits. American institutions could use the information to develop lucrative vaccines or treatments. The agreement lacks clear terms on how Kenya would share in those profits, relying on future talks.
The funding replaces previous US support for HIV and general health programs. Kenya must increase its own health spending over the five-year period. The US strategy aims to build up domestic health systems to end reliance on aid. Critics argue this approach risks repeating vaccine inequity seen in the last pandemic, where data-sharing countries waited longest for treatments.
Health experts warn the bilateral pact could undermine the WHO framework. They fear Kenya might give away valuable genetic sequence data without guaranteed benefits. American institutions could use the information to develop lucrative vaccines or treatments. The agreement lacks clear terms on how Kenya would share in those profits, relying on future talks.
The funding replaces previous US support for HIV and general health programs. Kenya must increase its own health spending over the five-year period. The US strategy aims to build up domestic health systems to end reliance on aid. Critics argue this approach risks repeating vaccine inequity seen in the last pandemic, where data-sharing countries waited longest for treatments.
